ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
뇌졸중 관리 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 7.6%를 나타내 578억 8,000만 달러로 성장할 전망입니다. 예측 기간의 성장은 신경보호요법의 출현, 뇌졸중 진단에서의 인공지능, 맞춤형 의료 접근법, 급성기 의료에 대한 접근 확대, 세계적인 뇌졸중 의료의 표준화 등에 기인한다고 생각됩니다. 예측 기간의 주요 동향에는 의료 영상 기술의 진보, 원격 의료 및 원격 모니터링, 예방 의료 및 위험 요인 관리의 중시, 신경보호 요법 및 약물 혁신, 협력 및 집학적 접근 등이 포함됩니다.
향후 5년간의 성장률 7.6%라고 하는 예측은 전회의 예측으로부터 0.2%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 무역 마찰은 프랑스와 싱가포르에서 개발된 로봇형 외골격과 신경가소성 트레이닝 소프트웨어의 가격을 올려 회복 기간의 장기화와 신경 재활 비용의 상승을 초래하여 미국의 뇌졸중 후 재활에 지장을 초래할 수 있습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.
만성질환의 이환율 상승은 향후 뇌졸중 관리 시장 성장을 이끌 것으로 예측됩니다. 만성 질환이란 1년 이상 지속되어 일상생활에 지장을 주었으며, 종종 지속적인 의료가 필요한 상태를 말합니다. 뇌졸중 관리는 예방의료, 교육, 환자의 임파워먼트에 주력함과 동시에, 1차 의료와 2차 의료를 조합한 통합 케어 제공 모델을 개발함으로써, 암이나 심혈관 질환 등 다양한 만성 질환의 환자를 서포트하는데 중요한 역할을 하고 있습니다. 예를 들어, 2022년 8월 미국에 본사를 둔 비영리 의학 단체인 미국 심장병학회의 보고서는 미국의 4대 심혈관계 위험인자 모두가 2025년에서 2060년에 걸쳐 증가할 것으로 예측했습니다. 당뇨병이 가장 현저하게 증가하고 39.3% 증가한 5,500만명, 이어 지질이상증(27.6% 증가의 1억 2,600만명), 고혈압(25.1% 증가의 1억 6,200만명), 비만(18.3% 증가의 1억 2,600만명)이 계속될 것으로 예상된다 또한 뇌졸중(33.8%→1,500만명), 심부전(33.4%→1,300만명), 허혈성 심질환(30.7%→2,900만명), 심장 발작(16.9%→1,600만명) 등 심혈관 질환의 대폭적인 증가가 예상됩니다. 그러므로 만성질환의 이환율 증가는 뇌졸중 관리 시장 성장을 이끌고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 뇌졸중 관리 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 뇌졸중 관리 시장 : 성장률 분석
세계의 뇌졸중 관리 시장 실적 : 규모와 성장(2019-2024년)
세계의 뇌졸중 관리 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 뇌졸중 관리 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 뇌졸중 관리 시장 : 제품 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
진단
약물 치료 제품
중재적 뇌졸중 관리 시스템
세계의 뇌졸중 관리 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
허혈성 뇌졸중
출혈성 뇌졸중
세계의 뇌졸중 관리 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원
클리닉
외래수술센터(ASC)
진단센터
소매 약국
온라인 약국
기타 최종 사용자
세계의 뇌졸중 관리 시장 : 진단 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
영상 시스템
진단 소프트웨어
혈액 검사
세계의 뇌졸중 관리 시장 : 약물 치료 제품 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
항응고제
항혈소판제
혈전 용해제
항고혈압제
세계의 뇌졸중 관리 시장 : 중재적 뇌졸중 관리 시스템 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
혈전 제거 장치
스텐트 리트리버
색전 방지 장치
경동맥 스텐트 시스템
제7장 지역별/국가별 분석
세계의 뇌졸중 관리 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 뇌졸중 관리 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
뇌졸중 관리 시장 : 경쟁 구도
뇌졸중 관리 시장 : 기업 프로파일
GE HealthCare Technologies Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Abbott Laboratories : 개요, 제품 및 서비스, 전략 및 재무 분석
Medtronic plc : 개요, 제품 및 서비스, 전략 및 재무 분석
Boston Scientific Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
B Braun Melsungen AG : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Bristol Myers Squibb Co.
Cardinal Health Inc.
Siemens Healthineers
Merck And Co. Inc.
Asahi Intech Co. Ltd.
Johnson & Johnson
Penumbra Inc.
Teleflex Inc.
Stryker Corporation
Biogen Inc.
Bayer AG
Philips Healthcare
AstraZeneca Plc.
F. Hoffmann-la Roche
Novartis AG
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
뇌졸중 관리 시장(2029년) : 새로운 기회를 제공하는 국가
뇌졸중 관리 시장(2029년) : 새로운 기회를 제공하는 부문
뇌졸중 관리 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
KTH
영문 목차
영문목차
Stroke management involves the treatment administered when a blood vessel in the brain bursts or when something obstructs the blood flow to a specific area of the brain, resulting in the brain aging or sustaining damage.
The primary product categories within stroke management include diagnostics, drug therapy products, and interventional stroke management systems. Diagnostics pertain to procedures aimed at identifying a disease, ailment, or injury based on its symptoms and indications. These diagnostic tools find applications in various scenarios such as ischemic stroke and hemorrhagic stroke. Additionally, they cater to diverse end-users, including hospitals, clinics, ambulatory surgery centers, diagnostic centers, retail pharmacies, online pharmacies, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The stroke management market research report is one of a series of new reports from The Business Research Company that provides stroke management market statistics, including stroke management industry global market size, regional shares, competitors with a stroke management market share, detailed stroke management market segments, market trends and opportunities, and any further data you may need to thrive in the stroke management industry. This stroke management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The stroke management market size has grown strongly in recent years. It will grow from $40.24 billion in 2024 to $43.15 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to thrombolytic therapies, stroke prevention initiatives, rehabilitation techniques, telemedicine in stroke care, collaborative stroke networks.
The stroke management market size is expected to see strong growth in the next few years. It will grow to $57.88 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to emergence of neuroprotective therapies, artificial intelligence in stroke diagnosis, personalized medicine approaches, expanding access to acute care, global stroke care standardization. Major trends in the forecast period include advancements in medical imaging technology, telemedicine and remote monitoring, focus on preventive care and risk factor management, neuroprotective therapies and drug innovations, collaboration and multidisciplinary approaches.
The forecast of 7.6% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. post-stroke rehabilitation by inflating prices of robotic exoskeletons and neuroplasticity training software developed in France and Singapore, resulting in prolonged recovery periods and higher neurorehabilitation costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rising incidence of chronic diseases is expected to drive the growth of the stroke management market in the future. Chronic diseases are defined as conditions that persist for a year or longer and hinder daily activities, often requiring ongoing medical care. Stroke management plays a crucial role in supporting patients with various chronic conditions, such as cancer and cardiovascular diseases, by focusing on preventive care, education, and empowering patients, as well as developing integrated care delivery models that combine primary and secondary care. For instance, in August 2022, a report from the American College of Cardiology, a U.S.-based non-profit medical association, projected that all four major cardiovascular risk factors in the United States will increase from 2025 to 2060. Diabetes is expected to see the most significant rise, with a 39.3% increase to 55 million individuals, followed by dyslipidemia (27.6% to 126 million), hypertension (25.1% to 162 million), and obesity (18.3% to 126 million). Additionally, substantial increases in cardiovascular disease rates are anticipated, including stroke (33.8% to 15 million) and heart failure (33.4% to 13 million), with ischemic heart disease (30.7% to 29 million) and heart attack (16.9% to 16 million) following closely. Therefore, the increasing incidence of chronic diseases is driving the growth of the stroke management market.
The increasing geriatric population is expected to drive the growth of the stroke management market in the future. The geriatric population includes individuals aged 65 and older, a demographic characterized by various biological, sociological, and psychological changes associated with aging. For example, in January 2024, the Population Reference Bureau, a U.S.-based nonprofit organization focused on collecting and providing statistics, projected that the number of Americans aged 65 and older will rise from 58 million in 2022 to 82 million by 2050, marking a 47% increase. Therefore, the growing geriatric population is a significant factor propelling the growth of the stroke management market.
Major companies in the stroke management market are increasingly focused on developing neurovascular technology to improve the diagnosis, treatment, and recovery processes for stroke patients. Neurovascular technology includes medical devices, techniques, and procedures aimed at diagnosing, treating, and managing conditions related to the brain's blood vessels and the nervous system. For example, in October 2022, Medtronic, an Ireland-based company specializing in medical technologies, launched a new platform designed to accelerate innovation in stroke care. This platform combines advanced imaging and data analytics to enhance decision-making, streamline workflows, and improve patient outcomes during stroke interventions. The new technology aims to equip clinicians with better tools for rapid diagnosis and treatment, facilitating timely interventions that can significantly mitigate the effects of strokes on patients.
Major players in the stroke management market are directing their efforts towards introducing innovative products, such as a portfolio of Ischemic stroke solutions, to gain a competitive advantage. An example is MicroVention Inc., a US-based neuroendovascular medical device company, which launched the Eric retrieval device for treating ischemic stroke in the US in June 2023. Eric, a self-expanding laser-cut clot retriever, features multiple retrieval cages on a pusher wire delivery system. MicroVention emphasizes the device's atraumatic design, following natural vessel guidelines to provide mild outward radial force, minimal vessel wall contact, and remarkable flexibility.
In December 2022, Johnson & Johnson, a US-based pharmaceutical industry company, acquired Abiomed, Inc. This strategic move aimed to expand Johnson & Johnson's MedTech business growth, delivering cutting-edge medical innovations globally. Abiomed Inc., a US-based medical device technology company, specializes in developing and manufacturing stroke management devices, including heart pumps.
Major companies operating in the stroke management market include GE HealthCare Technologies Inc., Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, B Braun Melsungen AG, Bristol Myers Squibb Co., Cardinal Health Inc., Siemens Healthineers, Merck And Co. Inc., Asahi Intech Co. Ltd., Johnson & Johnson, Penumbra Inc., Teleflex Inc., Stryker Corporation, Biogen Inc., Bayer AG, Philips Healthcare, AstraZeneca Plc., F. Hoffmann-la Roche, Novartis AG, Takeda Pharmaceutical Company Ltd., Sanofi SA, Daiichi Sankyo Company Limited, Boehringer Ingelheim International GmbH, Pfizer Inc.
North America was the largest region in the stroke management market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global stroke management market report during the forecast period. The regions covered in the stroke management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the stroke management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The stroke management market includes revenues earned by entities by providing hyperacute care, acute care, rehabilitation, control of bleeding, and basic life support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Stroke Management Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on stroke management market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for stroke management ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The stroke management market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Diagnostics; Drug Therapy Products; Interventional Stroke Management Systems
2) By Application: Ischemic Stroke; Hemorrhagic Stroke
3) By End-User: Hospitals; Clinics; Ambulatory Surgery Centers; Diagnostic Centers; Retail Pharmacies; Online Pharmacies; Other End Users
Subsegments:
1) By Diagnostics: Imaging Systems; Diagnostic Software; Blood Tests
2) By Drug Therapy Products: Anticoagulants; Antiplatelet Drugs; Thrombolytic Agents; Antihypertensive Drugs
3) By Interventional Stroke Management Systems: Clot Retrieval Devices; Stent Retrievers; Embolic Protection Devices; Carotid Artery Stenting Systems
Companies Mentioned: GE HealthCare Technologies Inc.; Abbott Laboratories; Medtronic plc; Boston Scientific Corporation; B Braun Melsungen AG; Bristol Myers Squibb Co.; Cardinal Health Inc.; Siemens Healthineers; Merck And Co. Inc.; Asahi Intech Co. Ltd.; Johnson & Johnson; Penumbra Inc.; Teleflex Inc.; Stryker Corporation; Biogen Inc.; Bayer AG; Philips Healthcare; AstraZeneca Plc.; F. Hoffmann-la Roche; Novartis AG; Takeda Pharmaceutical Company Ltd.; Sanofi SA; Daiichi Sankyo Company Limited; Boehringer Ingelheim International GmbH; Pfizer Inc.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Stroke Management Market Characteristics
3. Stroke Management Market Trends And Strategies
4. Stroke Management Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Stroke Management Growth Analysis And Strategic Analysis Framework
5.1. Global Stroke Management PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Stroke Management Market Growth Rate Analysis
5.4. Global Stroke Management Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Stroke Management Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Stroke Management Total Addressable Market (TAM)
6. Stroke Management Market Segmentation
6.1. Global Stroke Management Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diagnostics
Drug Therapy Products
Interventional Stroke Management Systems
6.2. Global Stroke Management Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ischemic Stroke
Hemorrhagic Stroke
6.3. Global Stroke Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Ambulatory Surgery Centers
Diagnostic Centers
Retail Pharmacies
Online Pharmacies
Other End Users
6.4. Global Stroke Management Market, Sub-Segmentation Of Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Imaging Systems
Diagnostic Software
Blood Tests
6.5. Global Stroke Management Market, Sub-Segmentation Of Drug Therapy Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Anticoagulants
Antiplatelet Drugs
Thrombolytic Agents
Antihypertensive Drugs
6.6. Global Stroke Management Market, Sub-Segmentation Of Interventional Stroke Management Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Clot Retrieval Devices
Stent Retrievers
Embolic Protection Devices
Carotid Artery Stenting Systems
7. Stroke Management Market Regional And Country Analysis
7.1. Global Stroke Management Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Stroke Management Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
